SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: Global Continuous Glucose Monitoring (CGM Systems, Application, Diabetic Type, and Adoption by Age Group) Market to 2020

[March 06, 2014]

Research and Markets: Global Continuous Glucose Monitoring (CGM Systems, Application, Diabetic Type, and Adoption by Age Group) Market to 2020

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/rdpj9s/continuous) has announced the addition of the "Continuous Glucose Monitoring Market (CGM Systems, Application, Diabetic Type, and Adoption by Age Group) - Current Trends, Size, Share, Industry Analysis, Competitive Intelligence, Growth, Opportunities and Global Forecasts, 2012 - 2020" report to their offering.

The global continuous glucose monitors market generated revenue of $194.8 million in 2012 and is expected to reach market size of value $568.5 million by 2020, growing at a CAGR of 14.8% during 2013-2020.

This growth is attributed to increase in technological innovations, namely launch of artificial pancreas, convenience offered by CGM over self monitoring glucose devices, and earlier detection of the hypo & hyperglycemic events by CGM.

Global CGM market is segmented based on application as home settings, diagnostics and hospitals. Among all the application segments home settings is expected to generate maximum revenue by 2020.

North Ameica is the maximum revenue-generating segment across the globe, mainly due to rapid acceptance of innovative technology, well-penetrated reimbursement system when compared with other geographies and rise in patient pool. Asia Pacific is expected to grow at a faster rate due to large patient pool, geographical expansion of market players, increase in income levels and improved living standards of the people.


Key market players in this market include: Medtronics, Dexcom, Animas Corporation, Ypsomed AG, Omnipod and Miraculins, Inc., including others. The major strategy adopted by the market players across this geography is collaborations, product launches and approvals. Collaborations specifically focus on distribution and commercialization of the devices.

KEY BENEFITS

- The report ranks the factors that are responsible for accelerating the market growth driven by upper hand of CGM over self monitoring glucose devices, approval for artificial pancreas and many more

- Market is forecasted for period of seven years 2013 to 2020 with market revenues for 2 historic years of 2011 and 2012

- Identification and analysis of key pockets of investment for CGM manufacturers

- Identification of challenges that must be addressed and overcome in the CGM market to achieve fiscal success throughout the market

- Analysis of regulatory framework that regulates introduction of new CGM and puts light on reimbursement scenario

- The report identifies and profiles key market participants that would drive innovation in the CGM market

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Executive Summary

Chapter 3 Global Continuous Glucose Monitors Market Overview

Chapter 4 Continuous Glucose Monitoring Systems Market - By Devices

Chapter 5 Continuous Glucose Monitoring System Market - By Application

Chapter 6 Continuous Glucose Monitoring System Market - By Age

Chapter 7 CGM Systems Market By Geography

Chapter 8 Company Profiles

- Animas Corporation

- Dexcom Inc.

- Insulet Corporation

- Medtronic Inc.

- Novo Nordisk

- Roche

- Spring Health Solution Ltd.

- Ypsomed AG

For more information visit http://www.researchandmarkets.com/research/rdpj9s/continuous.


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved.